| No. |
Name Length
|
Chromosome No./Scaffold Id Scaffold Length |
BLAST (vs nr) |
Gene ontology |
| 11611 |
O_BomoMSG20450_internal:A_BomoMSG_c26687_g1_i6
156bp |
|
trafficking_protein_particle_complex_subunit_11_[Bombyx_mori] |
| GO:0005794 |
C |
Golgi apparatus |
| GO:0006810 |
P |
transport |
| GO:0016192 |
P |
vesicle-mediated transport |
|
| 11612 |
O_BomoMSG20451_5prime_partial:A_BomoMSG_c26688_g1_i1
413bp |
|
pancreatic_lipase-related_protein_2_[Bombyx_mori] |
| GO:0004620 |
F |
phospholipase activity |
| GO:0004806 |
F |
triglyceride lipase activity |
| GO:0005509 |
F |
calcium ion binding |
| GO:0005576 |
C |
extracellular region |
| GO:0005615 |
C |
extracellular space |
| GO:0006629 |
P |
lipid metabolic process |
| GO:0009395 |
P |
phospholipid catabolic process |
| GO:0016042 |
P |
lipid catabolic process |
| GO:0016787 |
F |
hydrolase activity |
| GO:0019376 |
P |
galactolipid catabolic process |
| GO:0046872 |
F |
metal ion binding |
| GO:0047372 |
F |
acylglycerol lipase activity |
| GO:0047714 |
F |
galactolipase activity |
| GO:0052689 |
F |
carboxylic ester hydrolase activity |
|
| 11613 |
O_BomoMSG20452_5prime_partial:A_BomoMSG_c26688_g1_i2
243bp |
|
pancreatic_lipase-related_protein_2_[Bombyx_mori] |
| GO:0004620 |
F |
phospholipase activity |
| GO:0004806 |
F |
triglyceride lipase activity |
| GO:0005509 |
F |
calcium ion binding |
| GO:0005576 |
C |
extracellular region |
| GO:0005615 |
C |
extracellular space |
| GO:0006629 |
P |
lipid metabolic process |
| GO:0009395 |
P |
phospholipid catabolic process |
| GO:0016042 |
P |
lipid catabolic process |
| GO:0016787 |
F |
hydrolase activity |
| GO:0019376 |
P |
galactolipid catabolic process |
| GO:0046872 |
F |
metal ion binding |
| GO:0047372 |
F |
acylglycerol lipase activity |
| GO:0047714 |
F |
galactolipase activity |
| GO:0052689 |
F |
carboxylic ester hydrolase activity |
|
| 11614 |
O_BomoMSG20453_5prime_partial:A_BomoMSG_c26689_g1_i1
170bp |
|
Uncharacterized_protein_OBRU01_24682_[Operophtera_brumata] |
|
| 11615 |
O_BomoMSG20454_complete:A_BomoMSG_c26689_g1_i2
234bp |
|
uncharacterized_protein_LOC101738199_[Bombyx_mori] |
|
| 11616 |
O_BomoMSG20455_3prime_partial:A_BomoMSG_c26690_g1_i1
532bp |
|
tigger_transposable_element-derived_protein_4_[Bombyx_mori] |
| GO:0003674 |
F |
molecular_function |
| GO:0003676 |
F |
nucleic acid binding |
| GO:0003677 |
F |
DNA binding |
| GO:0005575 |
C |
cellular_component |
| GO:0005634 |
C |
nucleus |
| GO:0008150 |
P |
biological_process |
|
| 11617 |
O_BomoMSG20456_complete:A_BomoMSG_c26690_g1_i1
176bp |
|
|
|
| 11618 |
O_BomoMSG20457_internal:A_BomoMSG_c26690_g1_i2
398bp |
|
tigger_transposable_element-derived_protein_4_[Bombyx_mori] |
| GO:0003674 |
F |
molecular_function |
| GO:0003676 |
F |
nucleic acid binding |
| GO:0003677 |
F |
DNA binding |
| GO:0005575 |
C |
cellular_component |
| GO:0005634 |
C |
nucleus |
| GO:0008150 |
P |
biological_process |
|
| 11619 |
O_BomoMSG20458_complete:A_BomoMSG_c26690_g1_i2
176bp |
|
|
|
| 11620 |
O_BomoMSG20459_3prime_partial:A_BomoMSG_c26690_g1_i3
216bp |
|
tigger_transposable_element-derived_protein_4_[Bombyx_mori] |
| GO:0003676 |
F |
nucleic acid binding |
| GO:0003677 |
F |
DNA binding |
| GO:0005634 |
C |
nucleus |
| GO:0007417 |
P |
central nervous system development |
|
| 11621 |
O_BomoMSG2045_complete:A_BomoMSG_c9921_g1_i1
409bp |
|
uncharacterized_protein_LOC110382604_[Helicoverpa_armigera] |
|
| 11622 |
O_BomoMSG20460_complete:A_BomoMSG_c26690_g1_i3
176bp |
|
|
|
| 11623 |
O_BomoMSG20461_complete:A_BomoMSG_c26691_g1_i1
251bp |
|
uncharacterized_protein_LOC101737800_isoform_X1_[Bombyx_mori] |
| GO:0000166 |
F |
nucleotide binding |
| GO:0001934 |
P |
positive regulation of protein phosphorylation |
| GO:0004672 |
F |
protein kinase activity |
| GO:0004674 |
F |
protein serine/threonine kinase activity |
| GO:0005123 |
F |
death receptor binding |
| GO:0005515 |
F |
protein binding |
| GO:0005524 |
F |
ATP binding |
| GO:0005737 |
C |
cytoplasm |
| GO:0005739 |
C |
mitochondrion |
| GO:0005886 |
C |
plasma membrane |
| GO:0006468 |
P |
protein phosphorylation |
| GO:0006915 |
P |
apoptotic process |
| GO:0007165 |
P |
signal transduction |
| GO:0010942 |
P |
positive regulation of cell death |
| GO:0012501 |
P |
programmed cell death |
| GO:0016020 |
C |
membrane |
| GO:0016032 |
P |
viral process |
| GO:0016301 |
F |
kinase activity |
| GO:0016310 |
P |
phosphorylation |
| GO:0016740 |
F |
transferase activity |
| GO:0031264 |
C |
death-inducing signaling complex |
| GO:0031625 |
F |
ubiquitin protein ligase binding |
| GO:0032403 |
F |
protein-containing complex binding |
| GO:0032757 |
P |
positive regulation of interleukin-8 production |
| GO:0032760 |
P |
positive regulation of tumor necrosis factor production |
| GO:0034612 |
P |
response to tumor necrosis factor |
| GO:0036289 |
P |
peptidyl-serine autophosphorylation |
| GO:0042327 |
P |
positive regulation of phosphorylation |
| GO:0042802 |
F |
identical protein binding |
| GO:0043065 |
P |
positive regulation of apoptotic process |
| GO:0043068 |
P |
positive regulation of programmed cell death |
| GO:0043123 |
P |
positive regulation of I-kappaB kinase/NF-kappaB signaling |
| GO:0043124 |
P |
negative regulation of I-kappaB kinase/NF-kappaB signaling |
| GO:0043234 |
C |
protein-containing complex |
| GO:0043235 |
C |
receptor complex |
| GO:0043410 |
P |
positive regulation of MAPK cascade |
| GO:0044257 |
P |
cellular protein catabolic process |
| GO:0045121 |
C |
membrane raft |
| GO:0045651 |
P |
positive regulation of macrophage differentiation |
| GO:0045944 |
P |
positive regulation of transcription by RNA polymerase II |
| GO:0046330 |
P |
positive regulation of JNK cascade |
| GO:0046777 |
P |
protein autophosphorylation |
| GO:0051092 |
P |
positive regulation of NF-kappaB transcription factor activity |
| GO:0051260 |
P |
protein homooligomerization |
| GO:0051291 |
P |
protein heterooligomerization |
| GO:0060545 |
P |
positive regulation of necroptotic process |
| GO:0070231 |
P |
T cell apoptotic process |
| GO:0070266 |
P |
necroptotic process |
| GO:0070513 |
F |
death domain binding |
| GO:0070926 |
P |
regulation of ATP:ADP antiporter activity |
| GO:0071356 |
P |
cellular response to tumor necrosis factor |
| GO:0071363 |
P |
cellular response to growth factor stimulus |
| GO:0097191 |
P |
extrinsic apoptotic signaling pathway |
| GO:0097342 |
C |
ripoptosome |
| GO:0097343 |
P |
ripoptosome assembly |
| GO:0097527 |
P |
necroptotic signaling pathway |
| GO:1901026 |
P |
ripoptosome assembly involved in necroptotic process |
| GO:1990000 |
P |
amyloid fibril formation |
| GO:2000377 |
P |
regulation of reactive oxygen species metabolic process |
| GO:2001237 |
P |
negative regulation of extrinsic apoptotic signaling pathway |
| GO:2001238 |
P |
positive regulation of extrinsic apoptotic signaling pathway |
| GO:2001240 |
P |
negative regulation of extrinsic apoptotic signaling pathway in absence of ligand |
|
| 11624 |
O_BomoMSG20462_5prime_partial:A_BomoMSG_c26693_g1_i1
411bp |
|
dihydroorotate_dehydrogenase_(quinone),_mitochondrial_isoform_X2_[Bombyx_mori] |
| GO:0003824 |
F |
catalytic activity |
| GO:0004152 |
F |
dihydroorotate dehydrogenase activity |
| GO:0005737 |
C |
cytoplasm |
| GO:0005739 |
C |
mitochondrion |
| GO:0005743 |
C |
mitochondrial inner membrane |
| GO:0005758 |
C |
mitochondrial intermembrane space |
| GO:0006207 |
P |
'de novo' pyrimidine nucleobase biosynthetic process |
| GO:0006221 |
P |
pyrimidine nucleotide biosynthetic process |
| GO:0016020 |
C |
membrane |
| GO:0016021 |
C |
integral component of membrane |
| GO:0016491 |
F |
oxidoreductase activity |
| GO:0016627 |
F |
oxidoreductase activity, acting on the CH-CH group of donors |
| GO:0044205 |
P |
'de novo' UMP biosynthetic process |
| GO:0055114 |
P |
obsolete oxidation-reduction process |
|
| 11625 |
O_BomoMSG20463_complete:A_BomoMSG_c26693_g1_i1
153bp |
|
hypothetical_protein_WN51_01485_[Melipona_quadrifasciata] |
|
| 11626 |
O_BomoMSG20464_5prime_partial:A_BomoMSG_c26693_g1_i2
298bp |
|
dihydroorotate_dehydrogenase_(quinone)_isoform_X1_[Bombyx_mori] |
| GO:0003824 |
F |
catalytic activity |
| GO:0004152 |
F |
dihydroorotate dehydrogenase activity |
| GO:0005737 |
C |
cytoplasm |
| GO:0005739 |
C |
mitochondrion |
| GO:0005743 |
C |
mitochondrial inner membrane |
| GO:0005758 |
C |
mitochondrial intermembrane space |
| GO:0006207 |
P |
'de novo' pyrimidine nucleobase biosynthetic process |
| GO:0006221 |
P |
pyrimidine nucleotide biosynthetic process |
| GO:0016020 |
C |
membrane |
| GO:0016021 |
C |
integral component of membrane |
| GO:0016491 |
F |
oxidoreductase activity |
| GO:0016627 |
F |
oxidoreductase activity, acting on the CH-CH group of donors |
| GO:0044205 |
P |
'de novo' UMP biosynthetic process |
| GO:0055114 |
P |
obsolete oxidation-reduction process |
|
| 11627 |
O_BomoMSG20465_complete:A_BomoMSG_c26693_g1_i2
153bp |
|
hypothetical_protein_WN51_01485_[Melipona_quadrifasciata] |
|
| 11628 |
O_BomoMSG20466_5prime_partial:A_BomoMSG_c26693_g1_i3
321bp |
|
dihydroorotate_dehydrogenase_(quinone)_isoform_X1_[Bombyx_mori] |
| GO:0003824 |
F |
catalytic activity |
| GO:0004152 |
F |
dihydroorotate dehydrogenase activity |
| GO:0005737 |
C |
cytoplasm |
| GO:0005739 |
C |
mitochondrion |
| GO:0005743 |
C |
mitochondrial inner membrane |
| GO:0005758 |
C |
mitochondrial intermembrane space |
| GO:0006207 |
P |
'de novo' pyrimidine nucleobase biosynthetic process |
| GO:0006221 |
P |
pyrimidine nucleotide biosynthetic process |
| GO:0016020 |
C |
membrane |
| GO:0016021 |
C |
integral component of membrane |
| GO:0016491 |
F |
oxidoreductase activity |
| GO:0016627 |
F |
oxidoreductase activity, acting on the CH-CH group of donors |
| GO:0044205 |
P |
'de novo' UMP biosynthetic process |
| GO:0055114 |
P |
obsolete oxidation-reduction process |
|
| 11629 |
O_BomoMSG20467_complete:A_BomoMSG_c26693_g1_i3
153bp |
|
hypothetical_protein_WN51_01485_[Melipona_quadrifasciata] |
|
| 11630 |
O_BomoMSG20468_5prime_partial:A_BomoMSG_c26694_g1_i2
465bp |
|
protein_TAPT1_homolog_[Helicoverpa_armigera] |
| GO:0003674 |
F |
molecular_function |
| GO:0005575 |
C |
cellular_component |
| GO:0008150 |
P |
biological_process |
| GO:0016020 |
C |
membrane |
| GO:0016021 |
C |
integral component of membrane |
|
| 11631 |
O_BomoMSG20469_complete:A_BomoMSG_c26695_g1_i1
330bp |
|
transmembrane_protein_120_homolog_isoform_X1_[Bombyx_mori] |
| GO:0003674 |
F |
molecular_function |
| GO:0005575 |
C |
cellular_component |
| GO:0016020 |
C |
membrane |
| GO:0016021 |
C |
integral component of membrane |
| GO:0045089 |
P |
positive regulation of innate immune response |
| GO:0050829 |
P |
defense response to Gram-negative bacterium |
|
| 11632 |
O_BomoMSG2046_complete:A_BomoMSG_c9921_g1_i1
152bp |
|
|
|
| 11633 |
O_BomoMSG20470_complete:A_BomoMSG_c26695_g1_i2
393bp |
|
transmembrane_protein_120_homolog_isoform_X1_[Bombyx_mori] |
| GO:0003674 |
F |
molecular_function |
| GO:0005575 |
C |
cellular_component |
| GO:0016020 |
C |
membrane |
| GO:0016021 |
C |
integral component of membrane |
| GO:0045089 |
P |
positive regulation of innate immune response |
| GO:0050829 |
P |
defense response to Gram-negative bacterium |
|
| 11634 |
O_BomoMSG20471_complete:A_BomoMSG_c26695_g1_i3
363bp |
|
transmembrane_protein_120_homolog_isoform_X2_[Bombyx_mori] |
| GO:0003674 |
F |
molecular_function |
| GO:0005575 |
C |
cellular_component |
| GO:0016020 |
C |
membrane |
| GO:0016021 |
C |
integral component of membrane |
| GO:0045089 |
P |
positive regulation of innate immune response |
| GO:0050829 |
P |
defense response to Gram-negative bacterium |
|
| 11635 |
O_BomoMSG20472_internal:A_BomoMSG_c26696_g1_i1
99bp |
|
hypothetical_protein_RR46_01242_[Papilio_xuthus] |
|
| 11636 |
O_BomoMSG20473_internal:A_BomoMSG_c26696_g3_i1
129bp |
|
hypothetical_protein_RR46_01242_[Papilio_xuthus] |
|
| 11637 |
O_BomoMSG20474_complete:A_BomoMSG_c26696_g3_i3
127bp |
|
RNA-directed_DNA_polymerase_from_mobile_element_jockey_[Danaus_plexippus_plexippus] |
|
| 11638 |
O_BomoMSG20475_5prime_partial:A_BomoMSG_c26696_g3_i3
116bp |
|
uncharacterized_protein_LOC110385835_[Bombyx_mori] |
|
| 11639 |
O_BomoMSG20476_5prime_partial:A_BomoMSG_c26697_g1_i2
252bp |
|
egl_nine_homolog_1_[Bombyx_mori] |
| GO:0001666 |
P |
response to hypoxia |
| GO:0005506 |
F |
iron ion binding |
| GO:0005515 |
F |
protein binding |
| GO:0005634 |
C |
nucleus |
| GO:0005737 |
C |
cytoplasm |
| GO:0005829 |
C |
cytosol |
| GO:0016491 |
F |
oxidoreductase activity |
| GO:0016705 |
F |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen |
| GO:0016706 |
F |
2-oxoglutarate-dependent dioxygenase activity |
| GO:0018401 |
P |
peptidyl-proline hydroxylation to 4-hydroxy-L-proline |
| GO:0019899 |
F |
enzyme binding |
| GO:0030821 |
P |
obsolete negative regulation of cAMP catabolic process |
| GO:0031418 |
F |
L-ascorbic acid binding |
| GO:0031543 |
F |
peptidyl-proline dioxygenase activity |
| GO:0031545 |
F |
peptidyl-proline 4-dioxygenase activity |
| GO:0032364 |
P |
oxygen homeostasis |
| GO:0043433 |
P |
negative regulation of DNA-binding transcription factor activity |
| GO:0045765 |
P |
regulation of angiogenesis |
| GO:0046872 |
F |
metal ion binding |
| GO:0051213 |
F |
dioxygenase activity |
| GO:0051344 |
P |
negative regulation of cyclic-nucleotide phosphodiesterase activity |
| GO:0055008 |
P |
cardiac muscle tissue morphogenesis |
| GO:0055114 |
P |
obsolete oxidation-reduction process |
| GO:0060347 |
P |
heart trabecula formation |
| GO:0060412 |
P |
ventricular septum morphogenesis |
| GO:0060711 |
P |
labyrinthine layer development |
| GO:0061418 |
P |
regulation of transcription from RNA polymerase II promoter in response to hypoxia |
| GO:0071731 |
P |
response to nitric oxide |
|
| 11640 |
O_BomoMSG20477_complete:A_BomoMSG_c26697_g1_i3
473bp |
|
egl_nine_homolog_1_[Bombyx_mori] |
| GO:0001666 |
P |
response to hypoxia |
| GO:0005506 |
F |
iron ion binding |
| GO:0005515 |
F |
protein binding |
| GO:0005634 |
C |
nucleus |
| GO:0005737 |
C |
cytoplasm |
| GO:0005829 |
C |
cytosol |
| GO:0016491 |
F |
oxidoreductase activity |
| GO:0016705 |
F |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen |
| GO:0016706 |
F |
2-oxoglutarate-dependent dioxygenase activity |
| GO:0018401 |
P |
peptidyl-proline hydroxylation to 4-hydroxy-L-proline |
| GO:0019899 |
F |
enzyme binding |
| GO:0030821 |
P |
obsolete negative regulation of cAMP catabolic process |
| GO:0031418 |
F |
L-ascorbic acid binding |
| GO:0031543 |
F |
peptidyl-proline dioxygenase activity |
| GO:0031545 |
F |
peptidyl-proline 4-dioxygenase activity |
| GO:0032364 |
P |
oxygen homeostasis |
| GO:0043433 |
P |
negative regulation of DNA-binding transcription factor activity |
| GO:0045765 |
P |
regulation of angiogenesis |
| GO:0046872 |
F |
metal ion binding |
| GO:0051213 |
F |
dioxygenase activity |
| GO:0051344 |
P |
negative regulation of cyclic-nucleotide phosphodiesterase activity |
| GO:0055008 |
P |
cardiac muscle tissue morphogenesis |
| GO:0055114 |
P |
obsolete oxidation-reduction process |
| GO:0060347 |
P |
heart trabecula formation |
| GO:0060412 |
P |
ventricular septum morphogenesis |
| GO:0060711 |
P |
labyrinthine layer development |
| GO:0061418 |
P |
regulation of transcription from RNA polymerase II promoter in response to hypoxia |
| GO:0071731 |
P |
response to nitric oxide |
|